The rounds this investor is named on, who it invests beside, and where it shows up.
Named on one round in the feed.
We invest in pioneering science that aims to redefine the standard of care and bring new medicines to patients.
Corporate venture armboehringer-ingelheim-venture.comSince 2026-11-09
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
SRTD Biotech A biotech company focused on developing new precision mRNA therapeutics | Seed Verified against 4 of 7 sources | $35.2M | 2026-11-09 | [ LEAD ] |